Like many biotech's small and large, it's take time to develop these products and then have to go through the clinical studies, but the fact that Replicel is already being tagged by a well known, well capitalized company, albeit from China, is pretty huge and shouldn't be ignored. Btw, welcome aboard.
Replicel
News 
Market Data 
Discover 
